Back
Editas Medicine, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
57
EDIT
Editas Medicine, Inc.
Last Price:
$2.68
Seasonality Move:
5%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and EDIT is experiencing buying pressure, which is a positive indicator for future bullish movement.
Editas Medicine, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.39 | Buy |
| 20-day SMA: | 2.41 | Buy |
| 50-day SMA: | 2.14 | Buy |
| 200-day SMA: | 2.59 | Buy |
| 8-day EMA: | 2.42 | Buy |
| 20-day EMA: | 1.93 | Buy |
| 50-day EMA: | 1.14 | Buy |
| 200-day EMA: | 0.36 | Buy |
Editas Medicine, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.56 | Buy |
| Relative Strength Index (14 RSI): | 64.05 | Buy |
| Chaikin Money Flow: | 838358 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.14 - 2.54) | Buy |
| Bollinger Bands (100): | (1.98 - 2.52) | Buy |
Editas Medicine, Inc. Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Editas Medicine, Inc. Stock
Is Editas Medicine, Inc. Stock a Buy?
-
Editas Medicine, Inc. share price is 2.67 while EDIT 8-day simple moving average is 2.39, which is a Buy signal.
-
The stock price of EDIT is 2.67 while Editas Medicine, Inc. 20-day SMA is 2.41, which makes it a Buy.
-
Editas Medicine, Inc. 50-day simple moving average is 2.14 while EDIT share price is 2.67, making it a Buy technically.
-
EDIT stock price is 2.67 and Editas Medicine, Inc. 200-day simple moving average is 2.59, creating a Buy signal.
EDIT Technical Analysis vs Fundamental Analysis
Buy
57
Editas Medicine, Inc. (EDIT)
is a Buy
Is Editas Medicine, Inc. a Buy or a Sell?
-
Editas Medicine, Inc. stock is rated a BuyThe current Editas Medicine, Inc. [EDIT] share price is $2.67. The Score for EDIT is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
Editas Medicine, Inc. Stock Info
Market Cap:
268.3M
Price in USD:
2.67
Share Volume:
1.1M
Editas Medicine, Inc. 52-Week Range
52-Week High:
4.54
52-Week Low:
0.91
Buy
57
Editas Medicine, Inc. (EDIT)
is a Buy
Editas Medicine, Inc. Share Price Forecast
-
What is the Editas Medicine, Inc. stock price today?The Editas Medicine, Inc. stock price is 2.67 USD today.
-
Will EDIT stock go up or go down?Editas Medicine, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Editas Medicine, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Editas Medicine, Inc. is not overvalued.
Is Editas Medicine, Inc. Stock a Buy?
-
Editas Medicine, Inc. share price is 2.67 while EDIT 8-day exponential moving average is 2.42, which is a Buy signal.
-
The stock price of EDIT is 2.67 while Editas Medicine, Inc. 20-day EMA is 1.93, which makes it a Buy.
-
Editas Medicine, Inc. 50-day exponential moving average is 1.14 while EDIT share price is 2.67, making it a Buy technically.
-
EDIT stock price is 2.67 and Editas Medicine, Inc. 200-day simple moving average is 0.36, creating a Buy signal.
Fundamental Analysis of Editas Medicine, Inc.
Is Editas Medicine, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.09 per share, an increase next quarter of $0.10 per share, an increase this year of $0.88 per share, and an increase next year of $0.19 per share.
Technical Analysis of Editas Medicine, Inc.
Should I short Editas Medicine, Inc. stock?
-
EDIT Moving Average Covergence Divergence (MACD) indicator is 0.56, suggesting Editas Medicine, Inc. is a Buy
-
Editas Medicine, Inc. Relative Strength Index (RSI) is 64.05, which suggest Editas Medicine, Inc. is overbought
-
The Bollinger Bands (25) for Editas Medicine, Inc. is (2.14 - 2.54), which suggest Editas Medicine, Inc. is a Buy
-
The Bollinger Bands (100) for Editas Medicine, Inc. is (1.98 - 2.52), which suggest Editas Medicine, Inc. is a Buy
* Editas Medicine, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.